PanGenomic Health (LON: NARA) joined the Access segment of the Aquis Stock Exchange on 12 April. The shares were already listed on the Canadian Stock Exchange, so the company was able to join the market without a new prospectus.
Management wants to tap the potential UK shareholder base interested in digital health investment. No new money was raised when the Aquis quotation started. Novum is corporate adviser.
The share price has stayed at 4.5p during the week and no trades have been reported. The Canadian share price is C$0.07 and it has fallen from C$0.25 since trading commenced last ...
